Lv4
480 积分 2022-02-26 加入
Novel GLP-1-based Medications for Type 2 Diabetes and Obesity
5个月前
已关闭
Biomaterials in inhalation and nasal drug delivery
5个月前
已完结
Is retatrutide (LY3437943), a GLP-1, GIP, and glucagon receptor agonist a step forward in the treatment of diabetes and obesity?
5个月前
已完结
Resveratrol-Loaded Dipalmitoylphosphatidylcholine Liposomal Large Porous Microparticle Inhalations for the Treatment of Bacterial Pneumonia Caused by Acinetobacter baumannii
9个月前
已完结
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
11个月前
已完结
Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity
11个月前
已完结
GLP1: the early steps of a success story
11个月前
已完结
皖公网安备34019202002308
